Table 4. Function of CD3⁺CD56⁺ T lymphocytes in the peripheral blood of patients with AML and ALL in relation to WBC count at diagnosis.

	Perforin	P*
AML-1	22.5% ± 4.53%	>0.05
AML-2	35.5% ± 4.80%	>0.05
ALL-1	21.3% ± 8.05%	>0.05
ALL-2	21.1% ± 1.82%	>0.05

AML-1,indicates acute myeloid leukemia patients with increased (>10 × 10⁹/L) WBC counts at the time of diagnosis;ALL-1, acute lymphocytic leukemia patients with increased (>10 × 10⁹/L) WBC counts at the time of diagnosis;AML-2, acute myeloid leukemia patients whose WBC counts were low (<10 × 10⁹/L) at diagnosis,ALL-2, acute lymphocytic leukemia patients whose WBC counts were low (<10 × 10⁹/L) at diagnosis. *One-way ANOVA.